文献速递牙周病

辅助局部牙周治疗对2型糖尿病合并牙周炎患者的疗效:系统综述与网状Meta分析

Efficacy of adjunctive local periodontal treatment for type 2 diabetes mellitus patients with periodontitis: A systematic review and network meta-analysis.
PubMed 文献 · J Dent · 2024-06-25

该研究通过系统综述与网状Meta分析纳入30项RCT共1224例2型糖尿病合并牙周炎患者,比较不同辅助局部治疗联合NSPT的效果。短期和中期他汀类或二甲双胍辅助局部治疗在减少PD和/或获得CAL方面显著优于SRP;长期他汀类额外PD减少和CAL获得最显著;仅PDT/LT在短期显著降低HbA1c。

要点

  • 他汀类或二甲双胍局部辅助NSPT可优于SRP减少PD和获得CAL。
  • 长期他汀类额外PD减少和CAL获得最显著,其次为抗生素。
  • 仅PDT/LT在短期显著降低HbA1c。

核心结论

  • 中度支持在NSPT基础上局部加用二甲双胍或他汀类可能较SRP联合或不联合安慰剂增强PD减少和CAL获得。

研究设计与样本

  • 系统综述与网状Meta分析,仅纳入RCT,共30项RCT、1224例患者,采用频率学模型。
  • 检索Cochrane、EMBASE、Google Scholar、MEDLINE、PubMed、opengrey.eu及ClinicalTrials.gov至2024年5月29日,无语言限制。

主要发现

  • 短期(2-3个月)和中期(4-6个月),他汀类或二甲双胍辅助局部治疗在减少PD和/或获得CAL方面显著优于SRP联合或不联合PDT/LT、植物疗法、多西环素、双膦酸盐、抗生素、抗菌剂或安慰剂。
  • 长期(>6个月),他汀类产生最显著的额外PD减少和CAL获得,其次为抗生素, compared to SRP with antiseptics or placebo。
  • 仅PDT/LT在短期较SRP联合或不联合他汀类、抗菌剂或安慰剂显著降低HbA1c。

关键数值与推荐

  • 短期和中期他汀类或二甲双胍辅助局部治疗显著优于SRP联合或不联合PDT/LT、植物疗法、多西环素、双膦酸盐、抗生素、抗菌剂或安慰剂减少PD和/或获得CAL。
  • 长期他汀类额外PD减少和CAL获得最显著,其次为抗生素, compared to SRP with antiseptics or placebo。
  • 仅PDT/LT在短期较SRP联合或不联合他汀类、抗菌剂或安慰剂显著降低HbA1c。

临床怎么用

  • 临床医生可优化辅助治疗,同时应对2型糖尿病合并牙周炎患者的全身与口腔健康挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the effectiveness of different adjunctive local treatments combined with non-surgical periodontal therapy (NSPT) to reduce pocket depth (PD), gain clinical attachment level (CAL), and/or reduce glycated hemoglobin (HbA1c) in individuals with both type 2 diabetes mellitus (T2DM) and periodontitis in a systematic review and network meta-analysis. DATA SOURCES: Publications were searched in Cochrane databases, EMBASE, Google Scholar, MEDLINE, PubMed, opengrey.eu, and www. CLINICALTRIALS: gov up to May 29, 2024 with no language restriction. STUDY SELECTION: Only randomized controlled trials (RCTs) were included. Network meta-analysis utilized frequentist models. DATA: The network meta-analysis of 30 RCTs involving 1224 patients revealed that, in short-term (2-3 months) and medium-term (4-6 months), adjunctive local treatment involving statins or metformin significantly outperformed scaling and root planning (SRP) with/without additional interventions such as photodynamic and laser therapies (PDT/LT), phytotherapy, doxycycline, bisphosphonates, antibiotics, antiseptics, or placebo for reducing PD and/or gaining CAL. In the long-term (>6 months), statins yielded the most significant additional PD reduction and CAL gain, followed by antibiotics, compared to SRP with antiseptics or placebo. Only PDT/LT demonstrated significantly greater HbA1c reduction in the short term compared to SRP with/without statins, antiseptics, or placebo. CONCLUSION: This study moderately supports that adding metformin or statins locally to NSPT may enhance PD reduction and CAL gain compared to SRP with/without placebo. CLINICAL SIGNIFICANCE: Clinicians are guided to optimize adjunctive therapies, enhancing the health of patients with type 2 diabetes and periodontitis. A strategic approach is proposed to tackle systemic and oral health challenges simultaneously.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Lin SY, Sun JS, Lin IP, et al. Efficacy of adjunctive local periodontal treatment for type 2 diabetes mellitus patients with periodontitis: A systematic review and network meta-analysis. J Dent. 2024. PMID: 38936456. doi:10.1016/j.jdent.2024.105212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。